Velesco Pharma has expanded and enhanced its formulation and analytical research and development capabilities with the acquisition of a new facility in Wixom, Mich.
Velesco Pharma will continue to offer both research and cGMP services including formulation development, analytical method development/validation, release and stability testing and cGMP clinical manufacturing. The move of Velesco Pharma’s laboratories to the expanded facility will occur before the end of the year.
“Our new laboratory is impressively designed and equipped, and we will be increasing our scientific team such that we can meet our clients’ growing demand for pharmaceutical formulation and analytical services,” said Dave Barnes, Ph.D., chief executive officer at Velesco. “We look forward to opening the doors of our new center of excellence and collaborating with our current and new clients to ensure the quality and responsiveness their drug development programs demand.”
About Velesco Pharmaceutical Services
Velesco Pharma was formed by former big pharma R&D colleagues and focuses on supporting early and later stage drug development. Velesco provides fast and cost-effective contract analytical development and drug formulation services along with cGMP clinical supplies offering a full range of non-sterile dosage forms. The team offers personalized project management, state-of-the-art facilities and an experienced laboratory staff leading to comprehensive research relationships. Please visit Velesco’s leadership team at Booth #2415 at AAPS PharmSci 360 in Washington, D.C. on November 4-7.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181023005188/en/
Contacts
Velesco Pharmaceutical Services
Gerry Cox, 734-545-0696
gerry.cox@velescopharma.com
Source: Velesco Pharmaceutical Services
View this news release online at:
http://www.businesswire.com/news/home/20181023005188/en
